Time in therapeutic range among warfarin users in Turkey: Are there enough data to set definitive criteria for reimbursement?
Enregistré dans:
Auteurs principaux: | Mehmet Akif Topcuoglu (Auteur), Ethem Murat Arsava (Auteur) |
---|---|
Format: | Livre |
Publié: |
KARE Publishing,
2021-06-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range
par: Lale Dinç Asarcıklı, et autres
Publié: (2021) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
par: Ahmet Hakan Ateş, et autres
Publié: (2021) -
Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
par: Leiliane Rodrigues Marcatto, et autres
Publié: (2018) -
Geographic Market Definition: The Case of Medicare-Reimbursed Skilled Nursing Facility Care
par: John R. Bowblis, et autres
Publié: (2011) -
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
par: Andreja Detiček, et autres
Publié: (2018)